Research progress of circRNA in breast cancer drug resistance / 国际外科学杂志
International Journal of Surgery
;
(12): 713-717, 2022.
Article
in Chinese
| WPRIM
| ID: wpr-954281
ABSTRACT
Breast cancer is the most common cancer among women worldwide, and it seriously threatens women′s life and health. circular RNA (circRNA) play a key role in the development and drug resistance of various cancers, including breast cancer. circRNA is an endogenous RNA molecule with a single-stranded closed structure, which has unique biological characteristics and function, and is a current research hotspot. This article will review circRNA as potential biomarkers to predict breast cancer drug resistance and therapeutic targets.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
International Journal of Surgery
Year:
2022
Type:
Article
Similar
MEDLINE
...
LILACS
LIS